SHANGHAI HENLIUS BIOTECH, INC. · 复宏汉霖
Last · HKSEHK$63.00-1.50 (-2.33%)close · yahoo · 39h ago
MA10MA20MA50
Market capHK$34.3B347.8M sh
P/E · TTM34.1fwd 35.1 · eps 1.85
Beta0.51vs S&P 500
Div yield—annual · TTM
52w range
HK$50.25HK$87.10
Volume4.1Msession
Issuer
Legal nameSHANGHAI HENLIUS BIOTECH, INC. · 复宏汉霖
HQHong Kong (HK)
ListingHK 2696
ISINCNE100003N76
SectorHealthcare
IndustryPharmaceuticals
CurrencyHKD
Entity registrycninfo:FZQY1031451
Org IDFZQY1031451
Websitewww.henlius.com
Employees3,762
AddressShanghai Henlius Biotech, Inc. Innov Tower 200233, Shanghai
| Revenue | HK$3.6B |
|---|---|
| Net income | HK$430.4M |
| Net margin | 12.0% |
| Return on equity | 9.5% |
| Period | 2026 |
Loading chart…
Documents
FormReporting forFiledFlags
Showing 5 of 37 filings